GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Ending Cash Position

GH Research (FRA:1KA) Ending Cash Position : €71.28 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is GH Research Ending Cash Position?

GH Research's Ending Cash Position for the quarter that ended in Mar. 2024 was €71.28 Mil.

GH Research's quarterly Ending Cash Position declined from Sep. 2023 (€80.99 Mil) to Dec. 2023 (€71.91 Mil) and declined from Dec. 2023 (€71.91 Mil) to Mar. 2024 (€71.28 Mil).

GH Research's annual Ending Cash Position declined from Dec. 2021 (€244.95 Mil) to Dec. 2022 (€156.66 Mil) and declined from Dec. 2022 (€156.66 Mil) to Dec. 2023 (€71.91 Mil).


GH Research Ending Cash Position Historical Data

The historical data trend for GH Research's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Ending Cash Position Chart

GH Research Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
0.45 4.85 244.95 156.66 71.91

GH Research Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.15 89.43 80.99 71.91 71.28

GH Research Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GH Research's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=152.181+-80.27
=71.91

GH Research's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=72.145+-0.861
=71.28


GH Research Ending Cash Position Related Terms

Thank you for viewing the detailed overview of GH Research's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


GH Research (FRA:1KA) Business Description

Traded in Other Exchanges
Address
28 Baggot Street Lower, Dublin, IRL, D02 NX43
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

GH Research (FRA:1KA) Headlines

No Headlines